AARD vs LI · $284.4M cap vs P/E 24, rev $16.06B
Aardvark Therapeutics, Inc. Common Stock (AARD) versus Li Auto Inc (LI) — a side-by-side from cached financials, not a winner call.
Aardvark Therapeutics, Inc. Common Stock (AARD) is a biotechnology company listed on US.
Li Auto Inc (LI) is a auto manufacturers company listed on US.
AARD does not have a complete income-statement cache yet.
Latest reported LI revenue for 2025-12-31 was $16.06B. Net income was $162.9M. Revenue was down 18.8% from 2024-12-31 to 2025-12-31. LI currently screens at market cap $26.62B and trailing P/E 24.2.
AARD currently screens at market cap $284.4M. LI currently screens at market cap $26.62B and trailing P/E 24.2.
Not investment advice. Open the AARD and LI stock pages for the full models.
Not investment advice.